QI Path works with organizations large and small, from global healthcare and biopharma companies, to federal, state and local public agencies. We customize each solution to match each customer’s objectives, timelines and budgets.
QI Path works with organizations large and small, from global healthcare and biopharma companies, to federal, state and local public agencies. We customize solutions to match each customer’s objectives, timelines and budget.
QI Path is a cost effective solution for managing risk effectively across the entire drug development continuum, from pre-clinical development through clinical trials and into CMC. Whether you’re a pharma company developing a pipeline of drug products or a CRO running clinical trials across multiple sites, countries and geographies, QI Path drives QbD and RBQM principles across the entire R&D continuum, using RACT or process-based frameworks.
QI Path helps healthcare providers improve patient safety, clinical quality and operational performance with a proactive risk management platform that is cost effective, easy to use and fast to deploy. QI Path’s proactive risk management platform helps healthcare organizations get out of reaction mode to establish a forward-looking stance to risk and advance the organization’s High Reliability journey.
Government agencies operate in an environment of intense scrutiny, constant budget competition and complex organizational dynamics. QI Path’s proven risk management platform helps public organizations quickly identify and address vulnerabilities in critical plans, processes and programs before they cause costly, high visibility failures that jeopardize funding, damage reputations and sometimes threaten lives.